You are here

elafibranor

Genfit bags FDA breakthrough tag on route to phase 3 in PBC

Genfit bags FDA breakthrough tag on route to phase 3 in PBC

Fierce Biotech

primary biliary cholangitis

clinical trials

Flag link:

The 20 Hottest Pipeline Drugs to Watch in 2019

The 20 Hottest Pipeline Drugs to Watch in 2019

BioSpace

VX-659 + tezacaftor + ivacaftor

valoctocogene roxaparvovec

Flag link:

While we wait for NASH data, Genfit reports positive elafibranor data in PBC patients

While we wait for NASH data, Genfit reports positive elafibranor data in PBC patients

Endpoints

Gilead Sciences

Intercept Pharma

clinical trials

Flag link:

GENFIT Receives Positive Safety Review for NASH Candidate Elafibranor

GENFIT Receives Positive Safety Review for NASH Candidate Elafibranor

CP Wire

Flag link:

Genfit launches a PhIII study for NASH drug

Genfit launches a PhIII study for NASH drug

Fierce Biotech

clinical trials

Flag link: